- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-02-02-2012
Pharmaceutical Technology
Pharmaceutical Technology, February 2012 Issue (PDF)
February 02, 2012
Issue PDF
36
2
Applying QbD Principles to Drug Substance Development and Manufacture : Inside ICHQ11
FDA and Justice Department Address Drug Quality Concerns
February 02, 2012
Washington Report
36
2
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
Sustainable Investment
February 02, 2012
From The Editor
36
2
Pharma announces plans for the year ahead at annual JPMorgan Global Healthcare conference.
Shipping with the Enemy?
February 02, 2012
Agent-in Place
36
2
A nickel's worth of free advice to the competition could come at the expense of your bottom line.
FDA's Social Media Insight
February 02, 2012
PharmTech Talk
36
2
Guidance offered on how to deal with off-label information requests.
Expanding Capabilities in the Pharmaceutical Cold Chain
February 02, 2012
Pharma Ingredients
36
2
As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities.
Evaluating Impurities in Drugs (Part I of III)
February 02, 2012
Peer-Reviewed Research
36
2
In Part I of a three-part article, the authors discuss what constitutes an impurity and the potential sources of impurities in APIs and finished drug products.
Reducing Common Cause Variation
February 02, 2012
Statistical Solutions
36
2
Where is the variability coming from and what have we done to minimize it?
Biomanufacturing Outlook
February 02, 2012
Outsourcing Outlook
36
2
Industry optimism is on the rise for 2012.
Formulation Development Forum: Boronate Cross-linked Micelles
February 02, 2012
Pharma Ingredients
36
2
A new class of nanoparticles hold promise for preventing premature drug release and offering greater accuracy and effectiveness in drug delivery.
Saving the Next Generation of Regulatory Scientists
February 02, 2012
Viewpoint
36
2
New educational programs are key to the industry's future and to safe, available drugs.
Report from India
February 02, 2012
In the Field
36
2
The Asian nation is strategizing to take the lead over its regional competitors in pharmaceutical exports.
In the Spotlight February 2012
February 02, 2012
In the Spotlight
36
2
New product reviews for February 2012.
Single-Use High Capacity Membrane Chromatography
February 02, 2012
BioForum
36
2
Debottlenecking downstream mAb purification.
An Enhanced Approach to Drug-Substance Development and Manufacture
February 02, 2012
Special Reports
36
2
FDA and industry expert working group representatives discuss the pending ICH Q11 guideline.
Inside ICH: ICH Implementation Support
February 02, 2012
Inside ICH
36
2
ICH Q8, Q9, and Q10 support and implications for the future.
Optimizing Adjuvant Filtration: A Technical Forum
February 02, 2012
Special Reports
36
2
Experts discuss solutions for filter bacterial retention and related challenges. Contains online bonus material.